ClearPoint Neuro Inc. (CLPT) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Clearpoint Neuro Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.453 Greetings and welcome to the ClearPoint Neuro, Inc. 00:00:02.453 -- 00:00:07.599 First Quarter 2026 Financial Results. At this time, all participants are in a listen-only 00:00:07.599 -- 00:00:12.223 mode. A question and answer session will follow the formal presentation. 00:00:12.223 -- 00:00:15.907 If anyone should require operator assistance, please press star zero on your telephone 00:00:15.907 -- 00:00:20.232 keypad. As a reminder, this conference is being recorded. 00:00:20.232 -- 00:00:24.055 Comments made on this call may include statements that are forward-looking within the 00:00:24.055 -- 00:00:29.516 meaning of securities laws. These forward-looking statements may include, without limitation, 00:00:29.516 -- 00:00:35.290 statements related to anticipated industry trends, the company's plans, prospects 00:00:35.290 -- 00:00:38.911 and strategies, both preliminary and projected. 00:00:38.911 -- 00:00:43.359 The size of total addressable markets or the market opportunity for the company's products 00:00:43.359 -- 00:00:48.427 and services. The company's expectations regarding the integration, performance, and 00:00:48.427 -- 00:00:53.596 anticipated benefits of its recent acquisition of ERAS Holdings Inc., including 00:00:53.596 -- 00:00:58.645 operational efficiencies and the impact on the company's financial condition and 00:00:58.645 -- 00:01:04.134 results of operations. the company's expectation for future development, regulatory 00:01:04.134 -- 00:01:10.144 approval, timing, commercialization, and the market for cell and gene therapies, 00:01:10.144 -- 00:01:15.293 and the anticipated adoption of the company's products and services for use in the delivery 00:01:15.293 -- 00:01:20.802 of gene and cell therapies, and m...